April 22, 2021
rocks and sand

Workshop efficiency & effectiveness

Today the whole team “zoomed in” on a digital workshop on “Efficiency & Effectiveness”. Nico Van de Venne was our coach. He gently guided us in discovering how we can organize our working days to be more efficient and less stressful. We learned what big rocks and sand can tell us about priorities. We learned how to make up a week planning providing time for the unexpected but especially for our non-work related activities. We learned how good Eisenhower was […]
March 14, 2021
Yannick Jonsson

Employee testimonial – Yannick Jönsson

In this testimonial our colleague Yannick tells us what it is like to work for Trevalco as a consultant. As a consultant, what are your main activities? Since I work at Trevalco I have executed multiple projects. As a CSV consultant it is my job to ensure correct testing and documentation when new software supporting pharmaceutical production is installed, existing software is updated or retired. On my current assignment, as an MBR project engineer I configure the electronic batch record […]
February 27, 2021
Team event: digital escape room

Digital escape room

2021’s new year event had to go digital, but nevertheless we had a great time with the whole team. First there was a business update by Tim, followed by introductions of new colleagues and some questions & answers. We skipped to the fun part of the evening after 30 minutes. All colleagues had received a food box delivered at their home by Cosmocafé. This was really delicious. For the vegetarians, like myself, there was a meat-free version. The fun part […]
February 20, 2021

Common FDA warning letter observations in 2020

Last year was a bizarre year and, hopefully, one of a kind. Not only did Covid-19 affect our personal and professional lives, it also had a huge impact on regulatory inspections which were delayed or executed remotely. In this article I present the main result of a data analysis on pharmaceutical FDA warning letters of 2020. I used the same tools as presented in one of my earlier articles on FDA warning letters. As shown on the pie chart below […]